FIRSTPICK closes €25M second fund to back Baltic founders before anyone else does
AI Summary1 min read
TL;DR
FIRSTPICK has secured €25 million for its second fund, focusing on early-stage investments in Baltic startups, exemplified by its 2021 backing of high-risk neurotech company Samphire Neuroscience.
Tags
Investors and fundingNext FeaturedFIRSTPICKventure capitalBaltic startupsearly-stage fundingneurotechnology
When FIRSTPICK backed Emilė Radytė in 2021, her company Samphire Neuroscience was still building its first product and the risk, by the fund’s own assessment, was high. There was no revenue, no clear route to market, and a proposition, a neurotechnology wearable for menstrual pain, that most European investors would have politely declined to engage […]
This story continues at The Next Web